Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures

Circulation

Volumn 106, Issue 22, 2002, Pages 2781-2786

  Tepper, Oren M ^a   Galiano, Robert D ^a   Capla, Jennifer M ^a   Kalka, Christoph ^b   Gagne, Paul J ^a   Jacobowitz, Glen R ^a   Levine, Jamie P ^a   Gurtner, Geoffrey C ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Angiogenesis; Collateral circulation; Diabetes mellitus

Indexed keywords

COLLAGEN; FIBRONECTIN; HEMOGLOBIN A1C; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CELL ADHESION; CELL PROLIFERATION; CLINICAL ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; STEM CELL;

AGED; ANIMALS; BLOOD VESSELS; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CELL SEPARATION; CELLS, CULTURED; COLLAGEN; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; FEMALE; FIBRONECTINS; FLOW CYTOMETRY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ISCHEMIA; LAMININ; MALE; MICE; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; STEM CELL TRANSPLANTATION; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037180517     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000039526.42991.93     Document Type: Article

References (31)

1. Abaci A, Oguzhan A, Kahraman S, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation. 1999;99:2239-2242.
2. Waltenberger J, Lange J, Kranz A. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals. Circulation. 2000;102:185-190.
3. Hink U, Li H, Mollnau H, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 2001;88:E14-E22.
4. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967.
5. Vasa M, Fichtlscherer S, Aicher A, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-E7.
6. Schatteman GC, Hanlon HD, Jiao C, et al. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest. 2000;106:571-578.
7. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221-228.
8. Murayama T, Tepper O, Silver M, et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol. 2002;30:967.
9. Gill M, Dias S, Hattori K, et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res. 2001;88:167-174.
10. Kalka C, Masuda H, Takahashi T, et al. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res. 2000;86:1198-1202.
11. Kalka C, Masuda H, Takahashi T, et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A. 2000;97:3422-3427.
12. Schratzberger P, Walter DH, Rittig K, et al. Reversal of experimental diabetic neuropathy by VEGF gene transfer. J Clin Invest. 2001;107:1083-1092.
13. Kawamoto A, Gwon HC, Iwaguro H, et al. Therapeutic potential endothelial progenitor cells for of ex vivo expanded myocardial ischemia. Circulation. 2001;103:634-637.
14. Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 2001;103:2885-2890.
15. Brooks PC, Klemke RL, Schon S, et al. Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo. J Clin Invest. 1997;99:1390-1398.
16. Kawamoto A, Gwon HC, Iwaguro H, et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Cir. culation. 2001;103:634-637.
17. Bischoff J. Cell adhesion and angiogenesis. J Clin Invest. 1997;100: S37-S39.
18. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest. 1999;103:1231-1236.
19. Pober JS, Gimbrone MA Jr, Lapierre LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol. 1986;137:1893-1896.
20. Dimmeler S, Aicher A, Vasa M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest. 2001;108:391-397.
21. Vasa M, Fichtlscherer S, Adler K, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation. 2001;103:2885-2890.
22. Llevadot J, Murasawa S, Kureishi Y, et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest. 2001;108:399-405.
23. Walter DH, Rittig K, Bahlmann FH, et al. Statin therapy accelerates reendothelialization: A novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation. 2002;105:3017-3024.
24. Duh E, Aiello LP. Vascular endothelial growth factor and diabetes: The agonist versus antagonist paradox. Diabetes. 1999;48:1899-1906.
25. Waltenberger J. Impaired collateral vessel development in diabetes: Potential cellular mechanisms and therapeutic implications. Cardiovasc Res. 2001;49:554-560.
26. Grant MB, May WS, Caballero S, et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med. 2002;8:607-612.
27. Rivard A, Silver M, Chen D, et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol. 1999;154:355-363.
28. Frank S, Hubner G, Breier G, et al. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem. 1995;270:12607-12613.
29. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480-1487.
30. Lashkari K, Hirose T, Yazdany J, et al. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity. Am J Pathol. 2000;156:1337-1344.
31. Iwaguro H, Yamaguchi J, Kalka C, et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation. 2002;105:732-738.